Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Harvard Case Solution & Analysis

This case is accelerated study Myelin Repair Foundation collaboration model for drug discovery. It highlights the problem of creating a multi-disciplinary and multi-institutional research collaboration, which is trying to create for the treatment of multiple sclerosis on the basis of a new scientific approach. The case provides detailed information about how the norms of scientific research and intellectual property should have been updated to enable collaboration. The current dilemma facing the CEO and chief operating officer of the fund is to establish strategic priorities for research, so that the treatment of MS may be ready in the next ten years. Strategic decisions must take into account the complexity of the drug, the uncertainty of commercial partners interested in therapeutic approach and limit donors to raise funds on the basis of the medium.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Karim R. Lakhani, Paul R Carlile Source: Harvard Business School 19 pages. Publication Date: March 1, 2010. Prod. #: 610074-PDF-ENG

Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Case Solution Other Similar Case Solutions like

Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration

Share This